Autoimmune Connect –

Chronic Disease

Our Latest Post in this Category:

The NIH Report on Autoimmune Disease, Part 2: Enhancing Research

NIH Report Shows Why The AIID Epidemic is Invisible An NIH research report on autoimmune disease, published May, 2022, explains why, despite affecting more Americans than cancer, autoimmune and immunoinflammatory diseases (AIIDs) remain an invisible epidemic. Autoimmunity is an orphaned research field of patchwork studies of some 80-150 individual diseases.

Read More »

Autoimmune Incidence & Prevalence: Why don’t we have good data on AIIDs? 

Since 2010, we have sought autoimmune disease (AIID) incidence and prevalence data. Despite efforts by independent organizations like AARDA/AA, AIR and many single disease groups, we never found total national autoimmune statistics. NIH/CDC statistics bury AIIDs within siloed categories: Arthritis, diabetes, or by medical specialty: rheumatology, neurology, dermatology, endocrine, etc.

Read More »

Stanford MedX Autoimmune 2014-17 Presentations by DrBonnie360

We are here republishing our 2014-17 Stanford MedX autoimmune presentations, plus unpublished material from our 2015 Autoimmune Workshop. As we develop our 2023 State of Autoimmunity Report, we’ve been revisiting our previous analyses. For another example, see our 2016-19 patient-centered vision and business opportunities post. In 2015, Bonnie conducted an

Read More »

Our pre-Covid vision of autoimmune business opportunities

Back in 2019, pre-Covid pandemic, we already saw attractive investment & business opportunities to meet the large and growing need in autoimmune and chronic immuno-inflammatory diseases. Despite being as prevalent as cancer and growing faster, these diseases remain invisible: under-recognized, under-researched and under-served. In particular, multiple medical specialty silos within

Read More »

Can Air Purifiers Fight COVID or Wildfire Smoke?

Two types of purifiers: filters and sanitizers There are two types of air purifiers—filters and sanitizers—though some combine both in one product (1). Filters, most effectively, high-efficiency particulate-arresting (HEPA) filters, remove physical particles like dust, pollen, and smoke from the air. This can help alleviate symptoms for people with allergies or

Read More »

Digital GI Health: Sam Holliday, CEO, Oshi Health – Part 2
Coordinating primary with specialty care, redesigning virtual GI care around patients

A continuation of Part 1. One of our B2B thought leadership interviews with digital health entrepreneurs working to improve the care of chronic conditions. We care particularly about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. This continues our interview with the CEO of Oshi Health, Sam Holliday. Oshi

Read More »

Digital GI Health – Sam Holliday, CEO, Oshi Health – Part 1 of 2
On post-COVID telehealth, digital healthcare, virtual-first primary and specialty care, and building the future of GI care

First 2021 post in our series of B2B thought leadership interviews with visionary digital health entrepreneurs working to improve care of chronic conditions. In keeping with our mission, we particularly care about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. Bonnie and Ellen were happy to finally interview digital

Read More »
autoimmune
Autoimmune Connect

The NIH Report on Autoimmune Disease, Part 2: Enhancing Research

NIH Report Shows Why The AIID Epidemic is Invisible An NIH research report on autoimmune disease, published May, 2022, explains why, despite affecting more Americans than cancer, autoimmune and immunoinflammatory diseases (AIIDs) remain an invisible epidemic. Autoimmunity is an orphaned research field of patchwork studies of some 80-150 individual diseases.

Read More »
autoimmune
Autoimmune Connect

Autoimmune Incidence & Prevalence: Why don’t we have good data on AIIDs? 

Since 2010, we have sought autoimmune disease (AIID) incidence and prevalence data. Despite efforts by independent organizations like AARDA/AA, AIR and many single disease groups, we never found total national autoimmune statistics. NIH/CDC statistics bury AIIDs within siloed categories: Arthritis, diabetes, or by medical specialty: rheumatology, neurology, dermatology, endocrine, etc.

Read More »
autoimmune
Autoimmune Connect

Stanford MedX Autoimmune 2014-17 Presentations by DrBonnie360

We are here republishing our 2014-17 Stanford MedX autoimmune presentations, plus unpublished material from our 2015 Autoimmune Workshop. As we develop our 2023 State of Autoimmunity Report, we’ve been revisiting our previous analyses. For another example, see our 2016-19 patient-centered vision and business opportunities post. In 2015, Bonnie conducted an

Read More »
autoimmune
Autoimmune Connect

Our pre-Covid vision of autoimmune business opportunities

Back in 2019, pre-Covid pandemic, we already saw attractive investment & business opportunities to meet the large and growing need in autoimmune and chronic immuno-inflammatory diseases. Despite being as prevalent as cancer and growing faster, these diseases remain invisible: under-recognized, under-researched and under-served. In particular, multiple medical specialty silos within

Read More »
autoimmune
Autoimmune Connect

Can Air Purifiers Fight COVID or Wildfire Smoke?

Two types of purifiers: filters and sanitizers There are two types of air purifiers—filters and sanitizers—though some combine both in one product (1). Filters, most effectively, high-efficiency particulate-arresting (HEPA) filters, remove physical particles like dust, pollen, and smoke from the air. This can help alleviate symptoms for people with allergies or

Read More »
B2B Strategic Consulting
Autoimmune Connect

Digital GI Health: Sam Holliday, CEO, Oshi Health – Part 2
Coordinating primary with specialty care, redesigning virtual GI care around patients

A continuation of Part 1. One of our B2B thought leadership interviews with digital health entrepreneurs working to improve the care of chronic conditions. We care particularly about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. This continues our interview with the CEO of Oshi Health, Sam Holliday. Oshi

Read More »
B2B Strategic Consulting
Autoimmune Connect

Digital GI Health – Sam Holliday, CEO, Oshi Health – Part 1 of 2
On post-COVID telehealth, digital healthcare, virtual-first primary and specialty care, and building the future of GI care

First 2021 post in our series of B2B thought leadership interviews with visionary digital health entrepreneurs working to improve care of chronic conditions. In keeping with our mission, we particularly care about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. Bonnie and Ellen were happy to finally interview digital

Read More »
autoimmune
Autoimmune Connect

Post-Viral Syndromes – A History of Neglect (Long COVID Part 2)
The emergence of post-Covid syndrome shines new light on post-viral syndromes

The emergence of post-COVID syndrome shines new light on the old problem of post-viral syndromes   In Part 1, we discussed how the rise of long covid shines new light on chronic post-viral disorders long ignored by researchers and clinicians. But this issue didn’t just appear with the SARS-COV-2 COVID-19 pandemic.

Read More »